Baxter International Inc. (NYSE:BAX) Given Average Recommendation of “Hold” by Brokerages

Shares of Baxter International Inc. (NYSE:BAXGet Free Report) have earned an average rating of “Hold” from the fourteen research firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $51.07.

A number of equities research analysts recently issued reports on the company. KeyCorp lowered their price objective on Baxter International from $53.00 to $51.00 and set an “overweight” rating on the stock in a research note on Monday, July 31st. Citigroup dropped their price target on shares of Baxter International from $47.00 to $45.00 and set a “neutral” rating on the stock in a research note on Monday, August 21st. Stifel Nicolaus lifted their price objective on shares of Baxter International from $54.00 to $56.00 in a research note on Wednesday, July 12th. started coverage on Baxter International in a research report on Thursday, August 17th. They set a “hold” rating on the stock. Finally, Barclays reduced their price target on Baxter International from $58.00 to $54.00 and set an “overweight” rating for the company in a research report on Monday, July 31st.

Read Our Latest Analysis on BAX

Institutional Trading of Baxter International

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Valeo Financial Advisors LLC bought a new position in Baxter International in the 4th quarter worth about $211,000. American International Group Inc. grew its stake in Baxter International by 6.3% in the fourth quarter. American International Group Inc. now owns 155,451 shares of the medical instruments supplier’s stock worth $7,923,000 after purchasing an additional 9,259 shares in the last quarter. CoreFirst Bank & Trust increased its holdings in Baxter International by 23.6% during the 4th quarter. CoreFirst Bank & Trust now owns 4,977 shares of the medical instruments supplier’s stock worth $254,000 after purchasing an additional 951 shares during the period. Van ECK Associates Corp bought a new stake in Baxter International during the 4th quarter valued at $386,000. Finally, North Star Investment Management Corp. lifted its holdings in shares of Baxter International by 95.6% in the 1st quarter. North Star Investment Management Corp. now owns 11,265 shares of the medical instruments supplier’s stock worth $457,000 after buying an additional 5,507 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.

Baxter International Stock Down 2.6 %

Baxter International stock opened at $40.60 on Friday. The company has a market capitalization of $20.56 billion, a PE ratio of -7.17, a PEG ratio of 2.95 and a beta of 0.60. Baxter International has a 12-month low of $37.35 and a 12-month high of $60.39. The firm’s fifty day moving average is $44.57 and its 200 day moving average is $42.87. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 2.54.

Baxter International (NYSE:BAXGet Free Report) last released its quarterly earnings data on Thursday, July 27th. The medical instruments supplier reported $0.55 EPS for the quarter, missing the consensus estimate of $0.59 by ($0.04). The firm had revenue of $3.71 billion for the quarter, compared to the consensus estimate of $3.79 billion. Baxter International had a negative net margin of 19.00% and a positive return on equity of 24.94%. As a group, sell-side analysts predict that Baxter International will post 2.55 EPS for the current fiscal year.

Baxter International Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 2nd. Shareholders of record on Friday, September 1st will be given a dividend of $0.29 per share. The ex-dividend date is Thursday, August 31st. This represents a $1.16 dividend on an annualized basis and a yield of 2.86%. Baxter International’s dividend payout ratio (DPR) is presently -20.49%.

About Baxter International

(Get Free Report

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit.

Further Reading

Analyst Recommendations for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with's FREE daily email newsletter.